Analysis of immunological mechanisms for antibody production to hepatitis B surface antigen.
乙型肝炎表面抗原抗体产生的免疫机制分析。
基本信息
- 批准号:60570317
- 负责人:
- 金额:$ 1.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1985
- 资助国家:日本
- 起止时间:1985 至 1986
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Enhancement of antibody production to hepatitis B surface antigen by anti-idiotypic antibody. Studies were undertaken to determine whether anti-idiotypic antibody against antibody to hepatitis B surface antigen (anti-HBS) could modulate in vitro anti-HBS production by human peripheral blood mononuclear cells stimulated with pokeweed mitogen. Peripheral blood mononuclear cells from patients positive for serum anti-HBs produced significantly increased amounts of anti-HBs by the addition of F <(ab')_2> fragments of anti-anti-HBs as well as purified HBsAg when compared to those in cultures with pokeweed mitogen alone, indicating that anti-idiotypic antibody modulates the immune response to HBsAg.2. In vitro synthesis of antibody to hepatitis B virus antigen by circulating lymphocytes from chronic HBsAg carriers and patients with acute hepatitis B. The synthesis of IgG, anti-HBs and anti-HBc was measured in pokeweed mitogen-stimulated cultures of peripheral blood mononuclear cells from chronic HBsAg carriers, patients with acute hepatitis B (HAB) and subjects with anti-HBs in serum (controls). Coculture experiments indicated that decreased B cell function and increased suppressor T cell function specific for HBsAg contributed to the lack of anti-HBs in serum of chronic HBsAg carriers and AHB patients during the recovery phase.3. Enhancement of antibody production to hepatitis B surface antigen by interleukin 2. We studied to assess whether induction of anti-HBs production by cultured lymphocytes which had been conducted with pokeweed mitogen could be replaced by interleukin 2 (IL2). In cultures stimulated with purified HBsAg and IL2, the comparable levels of anti-HBs production to those obtained in cultures stimulated with pokeweed mitogen alone occured when peripheral blood mononuclear cells from patients positive for serum anti-HBs and recipients of HBsAg vaccine were used as effector cells. However, IL2 alone did not induce anti-HBs production.
1。通过抗IDiotypic抗体增强对乙型肝炎表面抗原的抗体产生。进行研究以确定抗丙型肝炎表面抗原(抗HBS)抗体的抗二动抗体是否可以通过人外周血单核细胞在用pokeweed sitiT刺激的人类外周血单核细胞中调节体外抗HBS的产生。与培养物相比,通过添加f <(ab')_ 2>抗HBS的F <(AB')_ 2>片段,与抗抗HBS的f <(ab')_ 2>片段相比,与培养物相比,血清抗HBS阳性的患者外周血单核细胞显着增加了抗HBS的量。仅用pokeweed有丝分裂原而表明抗IDiotypic抗体会调节对HBSAG的免疫反应2。通过慢性HBSAG载体和急性丙型肝炎的患者循环淋巴细胞的循环淋巴细胞和急性丙型肝炎B的循环淋巴细胞的体外合成。慢性HBSAG携带者,急性肝炎B(HAB)患者和血清中抗HBS的受试者(对照)。共培养实验表明,在恢复阶段,慢性HBSAG携带者和AHB患者的血清中缺乏抗HB的B细胞功能和抑制T细胞功能的降低和抑制剂T细胞功能增加。3。通过白介素2增强对丙型肝炎表面抗原的抗体产生。我们研究以评估是否可以通过介导的培养的淋巴细胞诱导抗HBS产生,这些淋巴细胞用pokeweed有丝分裂原进行的培养淋巴细胞可以用白介素2取代(IL2)。在用纯化的HBSAG和IL2刺激的培养物中,仅在外周血单核细胞中,抗Hbs的抗HBS产生水平可比的水平与在血清抗HBS阳性的患者和HBSAG疫苗的受益者阳性的患者中单独刺激的培养物中获得的可比水平。细胞。但是,仅IL2并未诱导抗HBS产生。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shinichi Kakumu: "Enhancement of autibody production to hepatitis B surface antigen by anti-idiotypic antibody." Gut. 27. 1069-1072 (1986)
Shinichi Kakumu:“通过抗独特型抗体增强乙型肝炎表面抗原的自身抗体产生。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kenichi Murase: "In vitro synthesis of antibody to hepatitis B virus antigen by circulating lymphocytes from chronic HBsAg carriers and patients with acute hepatitis B." Gastroenterologia Japonica. 21. 145-151 (1986)
Kenichi Murase:“通过慢性 HBsAg 携带者和急性乙型肝炎患者的循环淋巴细胞体外合成乙型肝炎病毒抗原抗体。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shinichi Kakumu: "Enhancement of antibody production to hepatitis B surface antigen by interleukin 2." Immunology Letters.
Shinichi Kakumu:“白细胞介素 2 增强乙型肝炎表面抗原的抗体产生。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAKUMU Shinichi其他文献
KAKUMU Shinichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAKUMU Shinichi', 18)}}的其他基金
Identification and clinical application for the role of NKT cells in patients with chronic hepatitis and hepatocellualr carcinoma infected hepatitis virus
NKT细胞在肝炎病毒感染的慢性肝炎及肝癌患者中的作用鉴定及临床应用
- 批准号:
15390236 - 财政年份:2003
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
To clarify the mechanism of chronicity and to explore therapeutic approach for viral hepatitis
阐明病毒性肝炎慢性机制并探索治疗途径
- 批准号:
12670529 - 财政年份:2000
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathologicl significance and its inhibition of apoptosis on the development and its progression of liver injury.
细胞凋亡对肝损伤发生发展的病理意义及其抑制作用。
- 批准号:
10470142 - 财政年份:1998
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
IMMUNO-PATHOGENESIS AND-THERAPY OF VIRAL HEPATITIS
病毒性肝炎的免疫发病机制和治疗
- 批准号:
09044341 - 财政年份:1997
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for international Scientific Research
Cellular immune response against HBV nucleocapsid antigen
针对 HBV 核衣壳抗原的细胞免疫反应
- 批准号:
07457593 - 财政年份:1995
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cellular immune response to core region protein of hepatitis C virus in patients with chronic hepatitis C
慢性丙型肝炎患者对丙型肝炎病毒核心区蛋白的细胞免疫反应
- 批准号:
05454245 - 财政年份:1993
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
RAB21在人外周血单个核细胞来源红细胞发育中的作用研究
- 批准号:82300260
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Comprehensive characterization of immune signaling networks in single-cells by joint quantification of proteins, protein complexes and mRNA
通过蛋白质、蛋白质复合物和 mRNA 的联合定量来全面表征单细胞中的免疫信号网络
- 批准号:
10636695 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Novel therapeutic intervention of early-stage T1D
早期 T1D 的新型治疗干预
- 批准号:
10698534 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection
与 HIV 感染相关的肠道菌群失调和心血管合并症的多组学特征
- 批准号:
10762411 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别:
Characterization of T cells in MOG antibody-associated disease
MOG 抗体相关疾病中 T 细胞的表征
- 批准号:
10737097 - 财政年份:2023
- 资助金额:
$ 1.15万 - 项目类别: